Fos expression in orexin neurons varies with behavioral state - PubMed (original) (raw)
Fos expression in orexin neurons varies with behavioral state
I V Estabrooke et al. J Neurosci. 2001.
Abstract
The neuropeptide orexin (also known as hypocretin) is hypothesized to play a critical role in the regulation of sleep-wake behavior. Lack of orexin produces narcolepsy, which is characterized by poor maintenance of wakefulness and intrusions of rapid eye movement (REM) sleep or REM sleep-like phenomena into wakefulness. Orexin neurons heavily innervate many aminergic nuclei that promote wakefulness and inhibit REM sleep. We hypothesized that orexin neurons should be relatively active during wakefulness and inactive during sleep. To determine the pattern of activity of orexin neurons, we recorded sleep-wake behavior, body temperature, and locomotor activity under various conditions and used double-label immunohistochemistry to measure the expression of Fos in orexin neurons of the perifornical region. In rats maintained on a 12 hr light/dark cycle, more orexin neurons had Fos immunoreactive nuclei during the night period; in animals housed in constant darkness, this activation still occurred during the subjective night. Sleep deprivation or treatment with methamphetamine also increased Fos expression in orexin neurons. In each of these experiments, Fos expression in orexin neurons correlated positively with the amount of wakefulness and correlated negatively with the amounts of non-REM and REM sleep during the preceding 2 hr. In combination with previous work, these results suggest that activation of orexin neurons may contribute to the promotion or maintenance of wakefulness. Conversely, relative inactivity of orexin neurons may allow the expression of sleep.
Figures
Fig. 1.
Camera lucida drawing illustrating the cell counting box in the perifornical region. In experiment 1, cells also were counted within boxes that sampled the lateral hypothalamic area and the area medial to the perifornical region. VMH, Ventromedial hypothalamic nucleus; Arc, arcuate hypothalamic nucleus; f, fornix; opt, optic tract; 3V, third ventricle. Each_dot_ represents an orexin-IR neuron.
Fig. 2.
A, Fos-IR nuclei are uncommon in perifornical orexin-IR neurons from a rat killed at ZT 3.B, A rat killed at ZT 15 has many Fos-IR nuclei in orexin-IR neurons. Arrow, Orexin-IR neuron;arrowhead, Fos-IR nucleus; double arrow, Fos-IR/orexin-IR neuron. Scale bar, 50 μm.
Fig. 3.
Fos expression in perifornical orexin neurons is higher during the night in rats maintained on a 12 hr LD cycle (ZT 3 through ZT 21 groups). In rats maintained in constant darkness (CT 3 and CT 15 groups), the percentage of double-labeling also is higher during the subjective night.
Fig. 4.
Orexin neurons in the perifornical region have the greatest diurnal variation in Fos expression. Orexin neurons medial to the perifornical region have a less striking diurnal variation, but Fos expression does not vary in orexin neurons of the lateral hypothalamic area. *p = 0.05; **p = 0.01.
Fig. 5.
Methamphetamine increases Fos expression in perifornical orexin neurons. *p = 0.003.
Fig. 6.
Sleep deprivation from ZT 5 to ZT 7 increases Fos expression in perifornical orexin-IR neurons. Sleep deprivation from ZT 17 to ZT 19 marginally increases Fos immunoreactivity in orexin-IR neurons. *p = 0.04; **p < 0.0001.
Fig. 7.
Across all three experiments, Fos expression in perifornical orexin-IR neurons correlates positively with the amount of wakefulness (r = 0.78; p < 0.0001) and negatively with the amounts of NREM (_r_= −0.78; p < 0.0001) and REM sleep (r = −0.63, p < 0.0001). ○, Experiment 1; ●, experiment 2; ■, experiment 3.
Similar articles
- Inhibition of rostral basal forebrain neurons promotes wakefulness and induces FOS in orexin neurons.
Satoh S, Matsumura H, Nakajima T, Nakahama K, Kanbayashi T, Nishino S, Yoneda H, Shigeyoshi Y. Satoh S, et al. Eur J Neurosci. 2003 Apr;17(8):1635-45. doi: 10.1046/j.1460-9568.2003.02577.x. Eur J Neurosci. 2003. PMID: 12752381 - Microdialysis perfusion of orexin-A in the basal forebrain increases wakefulness in freely behaving rats.
Thakkar MM, Ramesh V, Strecker RE, McCarley RW. Thakkar MM, et al. Arch Ital Biol. 2001 Apr;139(3):313-28. Arch Ital Biol. 2001. PMID: 11330208 - Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light-dark cycle and sleep-wake activities.
Yoshida Y, Fujiki N, Nakajima T, Ripley B, Matsumura H, Yoneda H, Mignot E, Nishino S. Yoshida Y, et al. Eur J Neurosci. 2001 Oct;14(7):1075-81. doi: 10.1046/j.0953-816x.2001.01725.x. Eur J Neurosci. 2001. PMID: 11683899 - To eat or to sleep? Orexin in the regulation of feeding and wakefulness.
Willie JT, Chemelli RM, Sinton CM, Yanagisawa M. Willie JT, et al. Annu Rev Neurosci. 2001;24:429-58. doi: 10.1146/annurev.neuro.24.1.429. Annu Rev Neurosci. 2001. PMID: 11283317 Review. - Orexin neuronal circuitry: role in the regulation of sleep and wakefulness.
Ohno K, Sakurai T. Ohno K, et al. Front Neuroendocrinol. 2008 Jan;29(1):70-87. doi: 10.1016/j.yfrne.2007.08.001. Epub 2007 Aug 29. Front Neuroendocrinol. 2008. PMID: 17910982 Review.
Cited by
- Single-Cell Profiling Uncovers Evolutionary Divergence of Hypocretin/Orexin Neuronal Subpopulations.
Sagi D, Tibi M, Admati I, Lerer-Goldshtein T, Hochgerner H, Zeisel A, Appelbaum L. Sagi D, et al. J Neurosci. 2024 Sep 4;44(36):e0095242024. doi: 10.1523/JNEUROSCI.0095-24.2024. J Neurosci. 2024. PMID: 39122556 - The Role of Orexin Receptor Antagonists in Inhibiting Drug Addiction: A Review Article.
Esmaili-Shahzade-Ali-Akbari P, Ghaderi A, Sadeghi A, Nejat F, Mehramiz A. Esmaili-Shahzade-Ali-Akbari P, et al. Addict Health. 2024 May;16(2):130-139. doi: 10.34172/ahj.2024.1491. Epub 2024 May 1. Addict Health. 2024. PMID: 39051042 Free PMC article. Review. - The nature and magnitude of cognitive impairment in narcolepsy type 1, narcolepsy type 2, and idiopathic hypersomnia: a meta-analysis.
Harel BT, Gattuso JJ, Latzman RD, Maruff P, Scammell TE, Plazzi G. Harel BT, et al. Sleep Adv. 2024 Jun 26;5(1):zpae043. doi: 10.1093/sleepadvances/zpae043. eCollection 2024. Sleep Adv. 2024. PMID: 39036743 Free PMC article. - Pivotal role of orexin signaling in the posterior paraventricular nucleus of the thalamus during the stress-induced reinstatement of oxycodone-seeking behavior.
Illenberger JM, Flores-Ramirez FJ, Pascasio G, Franco M, Mendonsa B, Martin-Fardon R. Illenberger JM, et al. J Psychopharmacol. 2024 Jul;38(7):647-660. doi: 10.1177/02698811241260989. Epub 2024 Jun 18. J Psychopharmacol. 2024. PMID: 38888086 - Effects of methamphetamine on actigraphy-based sleep parameters in female rhesus monkeys: Orexin receptor mechanisms.
Borgatti DA, Rowlett JK, Berro LF. Borgatti DA, et al. Drug Alcohol Depend. 2024 Jun 1;259:111285. doi: 10.1016/j.drugalcdep.2024.111285. Epub 2024 Apr 5. Drug Alcohol Depend. 2024. PMID: 38636173
References
- Abrahamson E, Moore R. Topographical organization of efferent projections arising from hypocretin (HC)-containing neuron populations located in the lateral hypothalamus. Soc Neurosci Abstr. 1999;25:1886.
- Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y, Fitch TE, Nakazato M, Hammer RE, Saper CB, Yanagisawa M. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell. 1999;98:437–451. - PubMed
- Cirelli C, Tononi G. On the functional significance of c-fos induction during the sleep-waking cycle. Sleep. 2000;23:453–469. - PubMed
- Edgar DM, Seidel WF. Modafinil induces wakefulness without intensifying motor activity or subsequent rebound hypersomnolence in the rat. J Pharmacol Exp Ther. 1997;283:757–769. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources